Mark D. Mulcair
Impact in
- Molecular Biology top 10%
- Cell death mechanisms and regulation
- Inflammasome and immune disorders
- DNA Repair Mechanisms
- Immunology top 10%
- interferon and immune responses
- Phagocytosis and Immune Regulation
Papers in
-
- CRISPR and Genetic Engineering 2
- DNA Repair Mechanisms 1
- Cell death mechanisms and regulation 1
- Genetics 5
- Bacterial Genetics and Biotechnology 4
- Co-authors
- M.J. Scanlon (8 shared papers)Sukhdeep K. Spall (1 shared paper)Andrew F. Wilks (1 shared paper)Catia L. Pierotti (1 shared paper)Jeffrey J. Babon (1 shared paper)Peter E. Czabotar (1 shared paper)Samuel N. Young (1 shared paper)Joanne M. Hildebrand (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (1 paper)Plant Biotechnology Journal (1 paper)ChemMedChem (1 paper)Australian Journal of Chemistry (1 paper)Cell (1 paper)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Mark D. Mulcair
12 papers receiving 852 citations
Mark D. Mulcair's Hit Papers
Peers
Comparison fields: 5 of 76
- Molecular Biology 687
- Immunology 203
- Molecular Medicine 27
- Cell Biology 79
- Biotechnology 35
Countries citing papers authored by Mark D. Mulcair
This map shows the geographic impact of Mark D. Mulcair's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Mulcair with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Mulcair more than expected).
Fields of papers citing papers by Mark D. Mulcair
This network shows the impact of papers produced by Mark D. Mulcair. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Mulcair. The network helps show where Mark D. Mulcair may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark D. Mulcair, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death Hit paper breakdown → | 2014 | 474 |
| 2 | 2006 | 100 | |
| 3 | 2015 | 75 | |
| 4 | 2014 | 46 | |
| 5 | 2000 | 45 | |
| 6 | 2008 | 44 | |
| 7 | 2009 | 36 | |
| 8 | 2014 | 27 | |
| 9 | 2016 | 7 | |
| 10 | 2018 | 6 | |
| 11 | 2014 | 3 | |
| 12 | 2015 | 1 |
About Mark D. Mulcair
Mark D. Mulcair is a scholar working on Molecular Biology, Genetics, Molecular Medicine, Immunology and Plant Science, having authored 12 papers that have together received 864 indexed citations. Recurring topics across this work include Bacterial Genetics and Biotechnology (4 papers), Antibiotic Resistance in Bacteria (2 papers), CRISPR and Genetic Engineering (2 papers), DNA Repair Mechanisms (1 paper), Click Chemistry and Applications (1 paper), Nitric Oxide and Endothelin Effects (1 paper), Quinazolinone synthesis and applications (1 paper) and Cell death mechanisms and regulation (1 paper). The work is most often cited by research in Molecular Biology (687 citations), Immunology (203 citations), Molecular Medicine (27 citations), Cell Biology (79 citations) and Biotechnology (35 citations). Mark D. Mulcair has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include M.J. Scanlon, Sukhdeep K. Spall, Andrew F. Wilks, Catia L. Pierotti, Jeffrey J. Babon, Peter E. Czabotar, Samuel N. Young, Joanne M. Hildebrand, Renwick C. J. Dobson and Andrew I. Webb. Their work appears in journals such as Journal of Medicinal Chemistry, Plant Biotechnology Journal, ChemMedChem, Australian Journal of Chemistry and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.